Shanxi Zhendong Pharmaceutical (300158.SZ) predicted a pre-tax loss, estimating a net loss of 1.15 to 1.35 billion yuan in 2024.

Shanxi Zhendong Pharmaceutical (300158.SZ) announced its performance forecast for the year 2024. The company expects a net loss attributable to shareholders of the listed company of 11.5 billion to 13.5 billion yuan for the year 2024; a net loss of 5.7 billion to 7.9 billion yuan after deducting non-operating gains and losses.